OUI Inc. introduction for futurecollaboration
PRODUCT INTRODUCTION:OUI Inc. (pronounced ‘wink’) is a Japanese startup that has developed a registered
medical device which is a smartphone attachment called the Smart Eye Camera,
making it possible to diagnose diseases in the eyelids, ocular surface, conjunctiva,cornea, anterior chamber, iris, crystal lens and anterior vitreous.
The Smart Eye Camera (SEC) is a patented smart phone attachment that can
produce a 1mm beam of light through the iPhone and has been certiﬁed as a class 1
medical device in Japan. As you may know, Japan's standards for approving medicaldevices are as strict as FDA and CE standards.

The Smart Eye Camera attachment can change the phone's light source into 3 typesof light (slit/white-diﬀused/ blue-diﬀused) that can help diagnose diseases such as
blepharitis, chalazion, sty, meibomian gland dysfunction, allergic conjunctivitis, dry
eye disease, infectious keratitis, keratitis ﬁlamentosa, corneal dystrophies,
trachoma, corneal perforation, cataract, glaucoma attack, and uveitis etc.

Its study in human experiments has been published in a peer-reviewed journal anddemonstrated high reproducibility in cataract diagnoses.
Competition-wise, there is not another smartphone device capable of producing
both a slit-lamp from the smartphone's light source as well as an examining
function. It's portability gives it the possibility to help those out in rural areas
developing countries where professional equipment is not portable andunaﬀordable.
This portability at a much more aﬀordable cost than standard equipment may raisequestions about it's eﬀectiveness in regards to the standard slit-lamp counterpartthat is used in most ophthalmology clinics. However, we have conducted a study thatproves its visibility results are just as clear as that to the standard equipment. On topof that, our app in development is aimed to be capable of recording video andpotentially diagnosing diseases using AI or will have video recording abilities with avideo transferring platform to Ophthalmologists for further analysis of the patient'seye condition.
This makes the market size for our product massive. According to The International
Agency for the Prevention of Blindness (IAPB) Vision Atlas, In 2015, 220 million
people suﬀer from middle to sever visual impairment with 36 million people being
blind. These numbers increase immensely to 587 million with middle/severe visualimpairment and 115 million blind in their 2050 projection.
Our mission is to reduce 50% of the world's blindness by year 2025. We have alreadydeveloped our product past prototype stages and are ready to distribute it across theglobe. However, we are still looking for collaborators and organizations to do pilot
projects with our SEC to get real feedback from its use in the ﬁeld.
We believe that our project ﬁts right in with many international development
programs due to our product’s innovation and the ability to drastically change theway people are diagnosed for their eye health as it addresses a problem on a global
scale.

ORGANIZATION DESCRIPTION:OUI Inc. was founded in 2016 by Ophthalmologists Eisuke Shimizu MD PhD andHiroyuki Yazu MD PhD who are now taking roles as CEO and Director respectively.
Currently, these two make up the Board of Directors but the two founders started
actively recruiting in 2019 where they recruited a Business Strategy Manager, aBusiness Strategy Chief, a VP of Global Business and a Sales Manager withintentions of still recruiting.
Current partnerships include the Blantyre Institute of Community Outreach (BICO)
in the Republic of Malawi which is chaired by Professor Khumbo Kalua, one of theleading Ophthalmologists in Malawi. OUI Inc. also started join research with Japan
International Eye Hospital in Vietnam and is in the process of launching joint
research with Lurio University in Mozambique.

In December 2019, OUI Inc. sent a mission for a pilot project with the SEC out torural clinics in the Republic of Malawi to directly meet the Organization leaders andsee the needs of the patients for themselves ﬁrst-hand. We understand that there
are many patients around the world in need but pilot projects like these help us
understand what logistical obstacles exist in each country that is preventing those inneed of receiving the help they need. Whether that be transportation, medicine,accurate diagnoses etc. We understand that inventing a product is not enough to
fulﬁll our mission, but rather to ensure we are actively ﬁnding smooth distribution
channels and making the product user friendly.
Photos of pilot project in Malawi:

In February 2020, OUI Inc. also invited Dr. Khumbo Kalua to Japan to meet withJapanese corporations, NGOs, and medical doctors to spark further collaborations
and speak about his organization and the SEC in Malawi.
Photos of Dr. Khumbo Kalua’s visit to Japan:

In our current corporate stage, these pilot projects are necessary to understand theobstacles of developing countries where our product may ﬂourish to help themaximum amount of people in need.
Recently, OUI Inc. has become a member of IAPB and our Smart Eye Camera (SEC)
device has been oﬀicially listed on their valued supplier list, making us the ﬁrst
Japanese corporation to do so.
Below are some links for your reference to this news:
https://www.businesswire.com/news/home/20200406005899/en/Smart-Eye-Camera-Li
sted-Valued-Supplier-List
Smart Eye Camera Got Listed in the Valued Supplier List of IAPB for the First Time as a Medical Device fro…

https://iapb.standardlist.org/the-products/smart-eye-camera-sec/
Smart Eye Camera (SEC) > IAPB Standard List • iapb.standardlist.org

This article alone has brought numerous amounts of inquiries from all over the world
asking for and about our product, and we see this collaboration with IAPB as
potential to ignite further possibilities for collaborations and partnerships, as we aim
to fulﬁll our mission. This would call for more pilot projects where we still needfunding for travel and preparations.
That is why we ask for help, oﬀer for future collaboration from all of you, our possible
partner, to get the SEC delivered all across the globe to get the proper diagnosis andtreatment that all people deserve.